These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent advances in antifungal chemotherapy. Petrikkos G; Skiada A Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625 [TBL] [Abstract][Full Text] [Related]
3. Management of invasive fungal infections: a role for polyenes. Chandrasekar P J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787 [TBL] [Abstract][Full Text] [Related]
4. Changing strategies for the management of invasive fungal infections. Rapp RP Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487 [TBL] [Abstract][Full Text] [Related]
5. Management of mycoses in surgical patients -- review of the literature. Holzheimer RG; Dralle H Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912 [TBL] [Abstract][Full Text] [Related]
6. Increasing fungal infections in the intensive care unit. De Pauw BE Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517 [TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of new antifungal agents. Kauffman CA Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366 [TBL] [Abstract][Full Text] [Related]
8. The changing epidemiology of invasive fungal infections: new threats. Maschmeyer G Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250 [TBL] [Abstract][Full Text] [Related]
10. New antifungal agents in pediatric practice. Das S; Shivaprakash MR; Chakrabarti A Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570 [TBL] [Abstract][Full Text] [Related]
11. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections. Cecil JA; Wenzel RP Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966 [TBL] [Abstract][Full Text] [Related]
12. [Invasive fungal infections in patients after liver transplantation]. Fischer L; Sterneck M Mycoses; 2005; 48 Suppl 1():27-35. PubMed ID: 15826284 [TBL] [Abstract][Full Text] [Related]
13. Voriconazole -- better chances for patients with invasive mycoses. Ghannoum MA; Kuhn DM Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915 [TBL] [Abstract][Full Text] [Related]
14. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Cornely OA Infection; 2008 Aug; 36(4):296-313. PubMed ID: 18642109 [TBL] [Abstract][Full Text] [Related]
15. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999. Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769 [TBL] [Abstract][Full Text] [Related]
16. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Fera MT; La Camera E; De Sarro A Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707 [TBL] [Abstract][Full Text] [Related]
17. Recent advances and challenges in the treatment of invasive fungal infections. Shao PL; Huang LM; Hsueh PR Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990 [TBL] [Abstract][Full Text] [Related]
18. [Fungal infections in children with malignant disease]. Michel G Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284 [TBL] [Abstract][Full Text] [Related]
19. The place for itraconazole in treatment. Maertens J; Boogaerts M J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632 [TBL] [Abstract][Full Text] [Related]
20. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Spanakis EK; Aperis G; Mylonakis E Clin Infect Dis; 2006 Oct; 43(8):1060-8. PubMed ID: 16983621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]